T2 Biosystems (TTOO)
(Delayed Data from NSDQ)
$1.44 USD
-0.03 (-2.04%)
Updated Oct 15, 2024 04:00 PM ET
After-Market: $1.45 +0.01 (0.69%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$1.44 USD
-0.03 (-2.04%)
Updated Oct 15, 2024 04:00 PM ET
After-Market: $1.45 +0.01 (0.69%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
T2 Biosystems (TTOO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
T2 Biosystems (TTOO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Are Options Traders Betting on a Big Move in T2 Biosystems (TTOO) Stock?
by Aditi Saraogi
Investors need to pay close attention to T2 Biosystems (TTOO) stock based on the movements in the options market lately.
T2 Biosystems (TTOO) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
T2 Biosystems (TTOO) delivered earnings and revenue surprises of 0.00% and 12.13%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Will T2 Biosystems (TTOO) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
T2 Biosystems (TTOO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Moving Average Crossover Alert: T2 Biosystems (TTOO)
by Zacks Equity Research
T2 Biosystems (TTOO) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
T2 Biosystems (TTOO) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
T2 Biosystems (TTOO) delivered earnings and revenue surprises of 0.00% and 1.11%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
T2 Biosystems (TTOO) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
T2 Biosystems (TTOO) delivered earnings and revenue surprises of -16.67% and 0.08%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
T2 Biosystems (TTOO) Jumps: Stock Rises 8.7%
by Zacks Equity Research
T2 Biosystems (TTOO) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.
T2 Biosystems (TTOO) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
T2 Biosystems (TTOO) delivered earnings and revenue surprises of 20.00% and 32.45%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Will T2 Biosystems (TTOO) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
T2 Biosystems (TTOO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is T2 Biosystems (TTOO) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (TTOO) Outperforming Other Medical Stocks This Year?
Is T2 Biosystems (TTOO) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (TTOO) Outperforming Other Medical Stocks This Year?
Is T2 Biosystems (TTOO) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (TTOO) Outperforming Other Medical Stocks This Year?
The Zacks Analyst Blog Highlights: TTOO, KMDA and CERS
by Zacks Equity Research
The Zacks Analyst Blog Highlights: TTOO, KMDA and CERS
3 Plasma Stocks to Win Big on FDA's Convalescent EUA
by Tirthankar Chakraborty
Convalescent plasma stocks moved northward following FDA's emergency plasma authorization for COVID-19 treatment. Here're three of them that should be on your watch list -
Is T2 Biosystems (TTOO) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (TTOO) Outperforming Other Medical Stocks This Year?
Do Options Traders Know Something About T2 Biosystems (TTOO) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to T2 Biosystems (TTOO) stock based on the movements in the options market lately.
T2 Biosystems (TTOO) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, T2 Biosystems (TTOO) closed at $1.66, marking a +1.84% move from the previous day.
T2 Biosystems (TTOO) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
T2 Biosystems' (TTOO) second-quarter results are likely to reflect growth in product revenues.
T2 Biosystems (TTOO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, T2 Biosystems (TTOO) closed at $1.62, marking a +0.62% move from the previous day.
T2 Biosystems (TTOO) Stock Moves -0.75%: What You Should Know
by Zacks Equity Research
In the latest trading session, T2 Biosystems (TTOO) closed at $1.33, marking a -0.75% move from the previous day.
Company News for Jul 2, 2020
by Zacks Equity Research
Companies in the news are: M, FDX, BYND, TTOO
Has T2 Biosystems (TTOO) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (TTOO) Outperforming Other Medical Stocks This Year?
Are Options Traders Betting on a Big Move in T2 Biosystems (TTOO) Stock?
by Zacks Equity Research
Investors need to pay close attention to T2 Biosystems (TTOO) stock based on the movements in the options market lately.
Has T2 Biosystems (TTOO) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (TTOO) Outperforming Other Medical Stocks This Year?